Bio-TechneMEX:TECH 83 EV-to-FCF is 39.51 as of Jun. 29, 2026, which is 20% below its 10-year median of 49.12. GuruFocus rates MEX:TECH with a GF Score™ of 83/100 and a GF Value™ of MXN1,112.56. The stock has 8 warning signs investors should review. Among 336 Biotechnology companies, Bio-Techne ranks worse than 74.4% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bio-Techne's Enterprise Value is MXN195,208 Mil.
Bio-Techne's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was MXN4,941 Mil. Therefore, Bio-Techne's EV-to-FCF for today is 39.51.
The historical rank and industry rank for Bio-Techne's EV-to-FCF or its related term are showing as below:
MEX:TECH'
s EV-to-FCF Range Over the Past 10 Years
Min: 25.58 Med: 49.12 Max: 80.52
Current: 41.34
During the past 13 years, the highest EV-to-FCF of Bio-Techne was 80.52. The lowest was 25.58. And the median was 49.12.
MEX:TECH's EV-to-FCF is ranked worse than 74.4% of 336
companies
in the Biotechnology industry
Industry Median: 14.7
vs MEX:TECH: 41.34
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bio-Techne's share price for today is MXN1090.00.
Bio-Techne's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN12.366.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Bio-Techne EV-to-FCF Related Terms
Bio-Techne EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Bio-Techne's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:TECH vs ARWR, CYTK, KRYS: EV-to-FCF Comparison
For the Biotechnology subindustry, Bio-Techne's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio-Techne's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Bio-Techne's EV-to-FCF falls into.
Bio-Techne's current Enterprise Value is MXN195,208 Mil.
Bio-Techne's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN4,941 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Techne (MEX:TECH) has a EV-to-FCF of 39.51 as of Jun. 29, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bio-Techne and its competitors. This is 20% below median its historical median of 49.12. Over the past decade, Bio-Techne's EV-to-FCF has ranged from 25.58 to 80.52. According to the industry distribution chart, Bio-Techne ranks #250 out of 336 companies in the Biotechnology industry, placing it in the top 74.4%.
Is Bio-Techne's EV-to-FCF too high?
Bio-Techne's current EV-to-FCF of 39.51 is 20% below median its 10-year median of 49.12. Over the past 10 years, this metric has ranged from a low of 25.58 to a high of 80.52. The Biotechnology industry median EV-to-FCF is 14.70. Bio-Techne's value of 39.51 is 168.8% above this industry median. Based on the distribution chart, Bio-Techne ranks #250 out of 336 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Bio-Techne has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's EV-to-FCF compare to ARWR and CYTK?
According to the Biotechnology industry distribution chart, Bio-Techne ranks #250 out of 336 companies for EV-to-FCF. This places Bio-Techne in the lower half of its industry. The industry median EV-to-FCF is 14.70. Bio-Techne's value of 39.51 is 168.8% above this benchmark. Historically, Bio-Techne's own EV-to-FCF has ranged from 25.58 to 80.52 over the past decade. While the company's 10-year median is 49.12 vs. the industry median of 14.70, Bio-Techne has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 14.70, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio-Techne's current EV-to-FCF of 39.51 is 168.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Bio-Techne and its competitors. For the Biotechnology industry, the median EV-to-FCF is 14.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio-Techne's current EV-to-FCF is 39.51, which is 20% below median its own 10-year median of 49.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Bio-Techne (MEX:TECH) has a current EV-to-FCF of 39.51. The stock's GF Value™ is MXN1,112.56, compared to a current price of MXN1,090.00 — trading 2% below its estimated fair value. The current EV-to-FCF is 39.51, which is 20% below median its 10-year median of 49.12 and 168.8% above the Biotechnology industry median of 14.70. Bio-Techne's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Bio-Techne (MEX:TECH), the current EV-to-FCF is 39.51 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio-Techne (MEX:TECH) Overvalued in 2026?
Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued.
The current stock price of MXN1,090.00 is trading 2% below its estimated GF Value™ of MXN1,112.56.
Key valuation signals for MEX:TECH:
EV-to-FCF: 39.51 (20% below median its 10-year median of 49.12)
GF Value™: MXN1,112.56 vs. price of MXN1,090.00 (2% below fair value)
Industry Position: 168.8% above the Biotechnology median (#250 of 336)
No single metric tells the full story. See the MEX:TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
83GF Score
Get the complete analysis for MEX:TECH
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TECH has been successfully added to your 
